DiaMedica Therapeutics Inc reports results for the quarter ended in September - Earnings Summary

DiaMedica Therapeutics

11/11/2021 24:19

* DiaMedica Therapeutics Inc  DMAC.OQ  reported a quarterly
adjusted loss of 18 cents​​ per share for the quarter ended in
September. The mean expectation of five analysts for the quarter
was for a loss of 23 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* DiaMedica Therapeutics Inc's reported EPS for the quarter was
a loss of 18 cents​.
* The mean earnings estimate of analysts had risen by about 7.6%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* DiaMedica Therapeutics Inc shares had risen by 12.0% this
quarter and lost 55.7% so far this year.
* The company reported a quarterly loss of $3.45 million.
* Wall Street's median 12-month price target for DiaMedica
Therapeutics Inc is $21.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated November 11 at 12:19 a.m.
 ​All figures in US dollars unless otherwise stated